Riders · Cancer Prevention and Research Institute of Texas · Article I: General Government
Unexpended Balances Between Biennia
Rider 7 in the 2026-27 Act, page I-18
Through the session
- 2024-25 Act In current law rider 8
- Introduced (Senate) Amended rider 7
- Introduced (House) Amended rider 7
- Senate substitute Unchanged rider 7
- House substitute Unchanged rider 7
- House passed Unchanged rider 7
- Conference Unchanged rider 7
- 2026-27 Act Unchanged rider 7
Pick any two steps to compare their wording.
What changed in the text
2024-25 Act → Introduced (House): 6 passages changed.
Removed words are struck through; added words are underlined. Sources: 2024-25 Act · Introduced (House).
Every version: numbers, statuses and source pages
| Version | Rider | Against the version before | Against the current budget | Source |
|---|---|---|---|---|
| 2024-25 ActGeneral Appropriations Act, 2024-25 Biennium | 8 | First version | — | Page I-20 |
| Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) | 7 was 8 | Amended | — | Page I-20 |
| Introduced (House)House Bill 1 as introduced (LBB recommended, House) | 7 was 8 | Amended | — | Page I-20 |
| Senate substituteCommittee Substitute for Senate Bill 1 | 7 | Unchanged | Amended | Page I-18 |
| House substituteHouse Committee Substitute for Senate Bill 1 | 7 | Unchanged | Amended | Page I-18 |
| House passedSenate Bill 1 as passed the second house | 7 | Unchanged | Amended | Page I-18 |
| ConferenceConference Committee Report for Senate Bill 1 | 7 | Unchanged | Amended | Page I-17 |
| 2026-27 ActGeneral Appropriations Act, 2026-27 Biennium | 7 | Unchanged | Amended | Page I-18 |
Full text of each wording
Introduced (Senate), Introduced (House), Senate substitute, House substitute, House passed, Conference, 2026-27 Act
Source, page I-18Unexpended Balances Between Biennia. Included in amounts appropriated above are any unexpended balances out of General Obligation Bond Proceeds (estimated to be $0) remaining as of August 31, 2025, in appropriations made to the Cancer Prevention and Research Institute of Texas and re-appropriated for the same purpose for the biennium beginning September 1, 2025. In addition to the amounts appropriated herein and above, all amounts previously appropriated to the Cancer Prevention and Research Institute of Texas out of General Obligation Bond Proceeds and awarded, obligated, or otherwise encumbered but not previously expended are appropriated for the same purpose for the biennium beginning September 1, 2025. The Cancer Prevention and Research Institute of Texas shall report the amount of encumbered but unexpended balances remaining as of August 31, 2025, and carried forward into the fiscal year beginning September 1, 2025, to the Legislative Budget Board no later than 30 calendar days after the end of the fiscal year.
2024-25 Act
Source, page I-20Unexpended Balances Between Biennia. Included in amounts appropriated above are any unexpended balances out of General Obligation Bond Proceeds (estimated to be $0) remaining as of August 31, 2023, in appropriations made to the Cancer Prevention and Research Institute of Texas and re-appropriated for the same purpose for the biennium beginning September 1, 2023. In addition to the amounts appropriated herein and above, all amounts previously appropriated to the Cancer Prevention and Research Institute of Texas out of General Obligation Bond Proceeds and awarded, obligated, or otherwise encumbered but not previously expended are appropriated for the same purpose for the biennium beginning September 1, 2023. The Cancer Prevention and Research Institute of Texas shall report the amount of encumbered but unexpended balances remaining as of August 31, 2023, and carried forward into the fiscal year beginning September 1, 2023, to the Legislative Budget Board no later than 30 days after the end of the fiscal year.